These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25372665)

  • 1. A non-invasive laboratory panel as a diagnostic and prognostic biomarker for thrombotic microangiopathy: development and application in a Chinese cohort study.
    Zhang T; Chen H; Liang S; Chen D; Zheng C; Zeng C; Zhang H; Liu Z
    PLoS One; 2014; 9(11):e111992. PubMed ID: 25372665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Serum C3 Concentration and Histologic Signs of Thrombotic Microangiopathy with Outcomes among Patients with ANCA-Associated Renal Vasculitis.
    Manenti L; Vaglio A; Gnappi E; Maggiore U; Allegri L; Allinovi M; Urban ML; Delsante M; Galetti M; Nicastro M; Pilato FP; Buzio C
    Clin J Am Soc Nephrol; 2015 Dec; 10(12):2143-51. PubMed ID: 26542163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies.
    Farkas P; Csuka D; Mikes B; Sinkovits G; Réti M; Németh E; Rácz K; Madách K; Gergely M; Demeter J; Prohászka Z
    Immunobiology; 2017 Feb; 222(2):119-127. PubMed ID: 27771173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features and outcomes in patients with thrombotic microangiopathy not associated with severe ADAMTS13 deficiency.
    Li A; Bendapudi PK; Uhl L; Hamdan A; Kaufman RM; Makar RS
    Transfusion; 2017 Sep; 57(9):2151-2158. PubMed ID: 28635017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of thrombotic microangiopathy and intimal hyperplasia with bleeding post-renal biopsy in antiphospholipid antibody-positive patients.
    Jordan N; Chaib A; Sangle S; Tungekar F; Sabharwal T; Abbs I; Khamashta M; D'Cruz D
    Arthritis Care Res (Hoboken); 2014 May; 66(5):725-31. PubMed ID: 24127353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal thrombotic microangiopathy associated to worse renal prognosis in Lupus Nephritis.
    Strufaldi FL; Menezes Neves PDMM; Dias CB; Yu L; Woronik V; Cavalcante LB; Malheiros DMAC; Jorge LB
    J Nephrol; 2021 Aug; 34(4):1147-1156. PubMed ID: 33570723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study.
    Bendapudi PK; Hurwitz S; Fry A; Marques MB; Waldo SW; Li A; Sun L; Upadhyay V; Hamdan A; Brunner AM; Gansner JM; Viswanathan S; Kaufman RM; Uhl L; Stowell CP; Dzik WH; Makar RS
    Lancet Haematol; 2017 Apr; 4(4):e157-e164. PubMed ID: 28259520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The spectrum of renal thrombotic microangiopathy in lupus nephritis.
    Song D; Wu LH; Wang FM; Yang XW; Zhu D; Chen M; Yu F; Liu G; Zhao MH
    Arthritis Res Ther; 2013 Jan; 15(1):R12. PubMed ID: 23320601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombotic microangiopathy in systemic lupus erythematosus: a cohort study in North Taiwan.
    Chen MH; Chen MH; Chen WS; Mu-Hsin Chang P; Lee HT; Lin HY; Huang DF
    Rheumatology (Oxford); 2011 Apr; 50(4):768-75. PubMed ID: 21149247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy.
    Chua JS; Baelde HJ; Zandbergen M; Wilhelmus S; van Es LA; de Fijter JW; Bruijn JA; Bajema IM; Cohen D
    J Am Soc Nephrol; 2015 Sep; 26(9):2239-47. PubMed ID: 25573909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocyte Involvement in Renal Thrombotic Microangiopathy: A Clinicopathological Study.
    Hu YF; Tan Y; Yu XJ; Wang H; Wang SX; Yu F; Zhao MH
    Am J Nephrol; 2020; 51(9):752-760. PubMed ID: 32862175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo thrombotic microangiopathy after kidney transplantation: clinical features, treatment, and long-term patient and graft survival.
    Caires RA; Marques ID; Repizo LP; Sato VA; Carmo LP; Machado DJ; de Paula FJ; Nahas WC; David-Neto E
    Transplant Proc; 2012 Oct; 44(8):2388-90. PubMed ID: 23026601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal Thrombotic Microangiopathy in Proliferative Lupus Nephritis: Risk Factors and Clinical Outcomes: A Case-Control Study.
    Barrera-Vargas A; Rosado-Canto R; Merayo-Chalico J; Arreola-Guerra JM; Mejía-Vilet JM; Correa-Rotter R; Gómez-Martín D; Alcocer-Varela J
    J Clin Rheumatol; 2016 Aug; 22(5):235-40. PubMed ID: 27464767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and renal biopsy findings predicting outcome in renal thrombotic microangiopathy: a large cohort study from a single institute in China.
    Yu XJ; Yu F; Song D; Wang SX; Song Y; Liu G; Zhao MH
    ScientificWorldJournal; 2014; 2014():680502. PubMed ID: 25184151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombotic microangiopathy versus class IV lupus nephritis in systemic lupus erythematosus.
    Alkhatib MH; Kant S; Menez S; Lakhani L; Sperati CJ; Fine DM; Arend LJ; Atta MG
    J Nephrol; 2021 Dec; 34(6):1907-1913. PubMed ID: 33689148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombotic microangiopathy in systemic lupus erythematosus: efficacy of eculizumab.
    El-Husseini A; Hannan S; Awad A; Jennings S; Cornea V; Sawaya BP
    Am J Kidney Dis; 2015 Jan; 65(1):127-30. PubMed ID: 25446020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.
    Cho BS; Yahng SA; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
    Transplantation; 2010 Oct; 90(8):918-26. PubMed ID: 20717073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analyses of data of patients with Thrombotic Microangiopathy in the WAA registry.
    Mörtzell M; Berlin G; Nilsson T; Axelsson CG; Efvergren M; Audzijoni J; Griskevicius A; Ptak J; Blaha M; Tomsova H; Liumbruno GM; Centoni P; Newman E; Eloot S; Dhondt A; Tomaz J; Witt V; Rock G; Stegmayr B
    Transfus Apher Sci; 2011 Oct; 45(2):125-31. PubMed ID: 21903476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance Validation of Three Scoring Systems for the Prediction of Thrombotic Microangiopathy Due to Severe ADAMTS13 Deficiency and the Response to Therapeutic Plasma Exchange: First Study in Korea.
    Park SH; Kim HK; Jeong J; Lee SH; Lee YJ; Kim YJ; Jo JC; Lim JH
    Ann Lab Med; 2023 Sep; 43(5):485-492. PubMed ID: 37080750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute myocardial infarction in thrombotic microangiopathies--clinical characteristics, risk factors and outcome.
    Patschan D; Witzke O; Dührsen U; Erbel R; Philipp T; Herget-Rosenthal S
    Nephrol Dial Transplant; 2006 Jun; 21(6):1549-54. PubMed ID: 16574680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.